Showing results (71-80 of 90) with videos related to

Sort By:
Pageof 9
The Journal of Pediatrics|December 3, 2014
Increased plasma incretin concentrations identifies a subset of patients with persistent congenital hyperinsulinism without KATP channel gene defectsYanqin Shi, Hima B Avatapalle, Mars S Skae, et al.
The Journal of Clinical Endocrinology and Metabolism|June 13, 2017
Atypical Forms of Congenital Hyperinsulinism in Infancy Are Associated With Mosaic Patterns of Immature Islet CellsBing Han, Zainab Mohamed, Maria Salomon Estebanez, et al.
The Journal of Clinical Endocrinology and Metabolism|October 12, 2021
Sustained Efficacy and Safety of Burosumab, a Monoclonal Antibody to FGF23, in Children With X-Linked HypophosphatemiaAgnès Linglart, Erik A Imel, Michael P Whyte, et al.
Frontiers in Endocrinology|June 5, 2013
Abnormal Neurodevelopmental Outcomes are Common in Children with Transient Congenital HyperinsulinismHima Bindu Avatapalle, Indraneel Banerjee, Sajni Shah, et al.
American Journal of Clinical Pathology|June 24, 2016
Enhanced Islet Cell Nucleomegaly Defines Diffuse Congenital Hyperinsulinism in Infancy but Not Other Forms of the DiseaseBing Han, Melanie Newbould, Gauri Batra, et al.
Orphanet Journal of Rare Diseases|December 3, 2016
Conservatively treated Congenital Hyperinsulinism (CHI) due to K-ATP channel gene mutations: reducing severity over timeMaria Salomon-Estebanez, Sarah E Flanagan, Sian Ellard, et al.
Frontiers in Endocrinology|November 3, 2018
Clinical Diversity in Focal Congenital Hyperinsulinism in Infancy Correlates With Histological Heterogeneity of Islet Cell LesionsRoss J Craigie, Maria Salomon-Estebanez, Daphne Yau, et al.
The New England Journal of Medicine|May 24, 2018
Burosumab Therapy in Children with X-Linked HypophosphatemiaThomas O Carpenter, Michael P Whyte, Erik A Imel, et al.
The Journal of Clinical Endocrinology and Metabolism|October 4, 2016
mTOR Inhibitors for the Treatment of Severe Congenital Hyperinsulinism: Perspectives on Limited Therapeutic SuccessMarie Szymanowski, Maria Salomon Estebanez, Raja Padidela, et al.
The Journal of Clinical Endocrinology and Metabolism|July 6, 2021
Zoledronic Acid vs Placebo in Pediatric Glucocorticoid-induced Osteoporosis: A Randomized, Double-blind, Phase 3 TrialLeanne M Ward, Anup Choudhury, Nathalie Alos, et al.
Pageof 9